The global vaccine facility Covax will help Pakistan’s vaccination programme protect millions of Pakistanis against COVID-19
The Covax (Covid-19 Vaccines Global Access Facility) initiative works towards the development, purchase and delivery of COVID-19 vaccines across more than 180 countries.
These countries, including Pakistan, will be given fair and early access to vaccines to help save lives.
Through the facility, 17 million doses of the Oxford University-Astra-Zeneca vaccine will be delivered to Pakistan over the coming months. The first 7 million are to be expected before April and the next 10 million are likely to come before June.
Protect 8.5 million lives
So far COVID-18 has claimed over 12,000 lives in Pakistan, but the vaccines will help protect 8.5 million people from the virus.
The UK has committed £548 million to the global Covax initiative and around £20 million of UK aid to help Pakistan fight the pandemic.
British High Commissioner Dr Christian Turner CMG said:
“The Covax facility has been the main way the world has united to make sure all countries get the vaccines they need as quickly as possible, including Pakistan. The UK has been a world leader in supporting Covax, and Covax has committed to supplying Pakistan with COVID-19 vaccines for 45m people this year.”
